Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
767
-
Total 13F shares, excl. options
-
85.5M
-
Shares change
-
+3.95M
-
Total reported value, excl. options
-
$16.4B
-
Value change
-
+$749M
-
Put/Call ratio
-
1.56
-
Number of buys
-
407
-
Number of sells
-
-286
-
Price
-
$191.42
Significant Holders of RESMED INC - COM (RMD) as of Q2 2024
863 filings reported holding RMD - RESMED INC - COM as of Q2 2024.
RESMED INC - COM (RMD) has 767 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (17.9M shares), BlackRock Inc. (11.7M shares), STATE STREET CORP (6.14M shares), Bank of New York Mellon Corp (5.77M shares), GEODE CAPITAL MANAGEMENT, LLC (3.48M shares), MORGAN STANLEY (3.4M shares), Invesco Ltd. (1.77M shares), NORTHERN TRUST CORP (1.47M shares), GOLDMAN SACHS GROUP INC (1.1M shares), and FMR LLC (1.02M shares).
This table shows the top 767 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.